Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |